Table 3. Food intake during the study.
Weekly FI (g, mean ± se) | ||||||||
Treatment | Wk 1&2 | Wk 3 | Wk 4 | Wk 5 | Wk 6 | Wk 7 | Wk 8 | Wk 9 |
DIO Veh | 23.7±0.5 | 23.4±0.6 | 22.3±0.6 | 22.9±0.5 | 22.6±0.3 | 25.1±0.7 | 22.3±0.4 | 22.0±0.5 |
CB1 ASO25 mg/kg/wk | 22.7±0.6 | 21.1±0.6 | 20.0±0.6* | 20.5±0.6 | 19.7±0.5* | 22.3±0.6* | 19.5±0.4* | 19.4±0.4* |
CB1 ASO12.5 mg/kg/wk | 23.6±0.6 | 22.7±0.6 | 22.2±0.6 | 21.7±0.9 | 21.5±1.0 | 24.3±0.7 | 21.7±0.7 | 21.1±0.6 |
CB1 ASO6.25 mg/kg/wk | 24.6±0.6 | 21.9±1.1 | 22.2±0.5 | 22.6±0.7 | 22.3±0.4 | 24.4±0.6 | 21.0±0.5 | 21.5±0.4 |
Control ASO25 mg/kg/wk | 24.2±0.6 | 23.4±0.5 | 22.8±0.5 | 23.4±0.6 | 22.1±0.5 | 26.8±0.7 | 22.7±0.6 | 21.9±0.6 |
One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.